Alignment Healthcare Overview
Valuation check: ALHC's ROE is 15.35%, below the Finance sector average of 16.71%.
Get informed when a big investor buys or sells
+ Follow15.35%
Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.
The latest ROE for ALHC is 15.35%. That is below the Finance sector average of 16.71%. Investors often review this figure alongside Alignment Healthcare's historical trend and sector peers before judging valuation or financial health.
Against Finance companies, ALHC currently prints 15.35% for ROE, while the sector average sits near 16.71%. That is roughly 8.1% below the sector mean. Large gaps often invite a closer look at Alignment Healthcare's growth, margins, and balance sheet.
Return on Equity shows how effectively Alignment Healthcare converts resources into returns. At 15.35%, ALHC may look efficient or underperforming depending on peer benchmarks and trend direction. Pair the percentage with revenue growth and leverage for a fuller health check.
After noting ALHC's ROE (15.35%), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.
This page's peer comparison chart is the fastest way to stack Alignment Healthcare's ROE against similar Finance names. You can also browse sector and industry screens on Stockcircle for a broader set of Finance companies and their key multiples and fundamentals.
